(Institución)/></a>
				</td>
				<td class= (Institución)
   (Nuevo usuario)
Ayuda  | Contacto  |  Castellano English  
 

Dadun > Depósito Académico > CIMA (Centro de Investigación Médica Aplicada) > Área de Oncología > Genética > DA - CIMA - Oncología - Genética - Artículos de revista >

Molecular heterogeneity in AML/MDS patients with 3q21q26 rearrangements
Autor(es) : Lahortiga, I. (Idoya)
Vazquez, I. (Iria)
Aguirre, X. (Xavier)
Larrayoz, M.J. (María J.)
Vizmanos, J.L. (José Luis)
Gozzetti, A. (A.)
Calasanz-Abinzano, M.J. (Maria Jose)
Odero, M.D. (Maria Dolores)
Palabras clave : Genetic Heterogeneity
Leukemia, Myeloid/genetics
Myelodysplastic Syndromes/genetics
Recombination, Genetic/genetics
Fecha incorporación: 2004
Editorial : Wiley-Blackwell
Versión del editor: http://bit.ly/vvvUlh
ISSN: 1098-2264
Cita: Lahortiga I, Vazquez I, Agirre X, Larrayoz MJ, Vizmanos JL, Gozzetti A, et al. Molecular heterogeneity in AML/MDS patients with 3q21q26 rearrangements. Genes Chromosomes Cancer 2004 Jul;40(3):179-189.
Resumen
Patients with 3q21q26 rearrangements seem to share similar clinicopathologic features and a common molecular mechanism, leading to myelodysplasia or acute myeloid leukemia (AML). The ectopic expression of EVI1 (3q26) has been implicated in the dysplasia that characterizes this subset of myeloid neoplasias. However, lack of EVI1 expression has been reported in several cases, and overexpression of EVI1 was detected in 9% of AML cases without 3q26 abnormalities. We report the molecular characterization of seven patients with inv(3)(q21q26), t(3;3)(q21;q26) or related abnormalities. EVI1 expression was detected in only one case, and thus ectopic expression of this gene failed to explain all of these cases. GATA2 (3q21) was found to be overexpressed in 5 of the 7 patients. GATA2 is highly expressed in stem cells, and its expression dramatically decreases when erythroid and megakaryocytic differentiation proceeds. No mutations in GATA1 were found in any patient, excluding loss of function of GATA1 as the cause of GATA2 overexpression. We report finding molecular heterogeneity in patients with 3q21q26 rearrangements in both breakpoints and in the expression pattern of the genes near these breakpoints. Our data suggest that a unique mechanism is not likely to be involved in 3q21q26 rearrangements.
Enlace permanente: http://hdl.handle.net/10171/19572
Aparece en las colecciones: DA - CIMA - Oncología - Genética - Artículos de revista
DA - Ciencias - Genética - Artículos de revista

Ficheros en este registro:
Fichero:  2004 GChrC 3q.pdf
Descripción: 
Tamaño:  1,59 MB
Formato:  Adobe PDF
 Visualizar / Abrir 

Los ítems de Dadun están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.